vimarsana.com
Home
Live Updates
Ionis announces new donidalorsen data and presentations at t
Ionis announces new donidalorsen data and presentations at t
Ionis announces new donidalorsen data and presentations at the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced additional positive interim data from a Phase 2 open-label extension (OLE) study of...
Related Keywords
Texas ,
United States ,
San Antonio ,
Richards Geary ,
,
Exchange Commission ,
American Academy Of Allergy Asthma Immunology ,
Prnewswire Ionis Pharmaceuticals Inc ,
Twitter ,
Ionis Pharmaceuticals Inc ,
Ionis Pharmaceuticals ,
Nasdaq ,
Angioedema Quality ,
American Academy ,
Allergy Asthma ,
Annual Meeting ,
Label Extension Study ,
Hereditary Angioedema ,
Updated Interim Analysis ,
Donidalorsen Treatment ,
Donidalorsen Taken Every ,
Conjugated Antisense ,
Nc ,